MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial)
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Acute pulmonary edema (APE) is a common condition in the emergency room, associated with
considerable mortality. The use of intravenous morphine in the treatment of APE remains
controversial and Benzodiazepines have been suggested as an alternative for morphine to
relieving dyspnoea and anxiety in the patients with APE. The MIdazolan versus MOrphine in APE
trial (MIMO) is a multicenter, prospective, open-label, randomized study designed to evaluate
the efficacy and safety of morphine in patients with APE.
Phase:
Phase 4
Details
Lead Sponsor:
Alberto DomÃnguez RodrÃguez Alberto Dominguez-Rodriguez